Zimmer stands to become one of the largest orthopedic device manufacturers in the United States if its $13.35 billion acquisition of Biomet goes through early next year. Combined revenues of the two companies from 2013 were about $7.8 billion, and together they will focus on knee, hip, surgical, spine, dental, sports medicine, extremities and trauma devices.
Today, Zimmer announced the acquisition of ETEX Holdings to enhance its biologics portfolio.
More articles on devices:
Zimmer purchases biologic therapeutics company ETEX
Medtronic to aid Syrian refugees in Jordan
Bacterin CEO to appear on FOX Business Network’s Open Bell
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
